| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5700779 | European Journal of Surgical Oncology (EJSO) | 2017 | 27 Pages |
Abstract
In matched cohorts of mid/high LARC patients, surgery alone provided comparable oncological outcome, when compared with NCRT. CRM involvement was the only risk factor for local recurrence in mid/high rectal cancer. NCRT may not be always needed in mid/high LARC. A threatened CRM could be diagnosed up front and prevented by selecting CRT for these patients.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Y. Zhang, Y. Sun, Z. Xu, P. Chi, X. Lu,